Abstract:The aberrant expression of Matrix Metalloproteinases (MMPs) is known to contribute to the pathogenesis of airway remodeling and alveolar disruption in chronic obstructive pulmonary diseases (COPD). This study explored the relationship between MMP genetic variants and the risk of COPD in family and population based studies. For the discovery stages, eleven COPD patients from five families were subjected to whole genome sequencing (WGS), and 21 common mutations in MMPs and TIMPs were identified. Of these mutations, two SNPs rs2664370 and rs2664369 in MMP16 remained significant differences (P < 0.0024 and P < 0.0024, respectively). In subsequent verification studies, the mutations were genotyped by SNPscan technology in 590 unrelated patients and 594 controls. Functionally, we found that MMP16 expression significantly increased in COPD patients and Cigarette Smoke Extract (CSE) treated 16HBE cells compared to controls. This was also confirmed by bioinformatic analysis. COPD subjects carrying rs2664370C alleles showed decreased levels of MMP16 in the plasma and PBMCs compared to those carrying CT and TT alleles. Treatment with hsa-miR-576-5p mimics led to a greater reduction in luciferase reporter activity in cells co-transfected with rs2664370CC. In addition, Base Excess (BE), PCO2 and PO2 levels in rs2664370CC were significantly lower than rs2664370CT+TT (P < 0.001, P = 0.019, and P = 0.026, respectively). Taken together, this demonstrates that the rs2664370T>C variant decreases the risk of COPD likely thorough increasing the interaction with hsa-miR-576-5p and reducing the expression of MMP16. Therefore, common mutations in MMP16 reduce COPD risk and improve plasma blood gas levels.Funding Statement: This work was supported by grants from the National Natural Science Foundation of China (81520108001, 81700043, 81770043, and 81220108001), Guangdong Natural Science Foundation (2016A030313593), Guangzhou Science and Technology Programs for Science Study (201607020030), the National Key R&D Project (2016YFC 0903700), the 973 Key Scheme of China (2015CB553406), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014, for WL), Guangdong Province Universities and Colleges Key Grant for Innovative Research (cxzd1142), Guangzhou Department of Education (1201620007, 13C08, and 12A001S), Open Project of State Key Laboratory of Respiratory Disease (SKLRD-OP-201808, SKLRD-QN-201719), Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2017BT01S155), and the National Key R&D Program of China (2018YFC1311900). Declaration of Interests: The authors declare: "None."Ethics Approval Statement: The study was approved by the Institutional Review Board of Guangzhou Medical University (Ethics Committee of the First Affiliated Hospital (GZMC2009-08-1336)) and adhered to the Declaration of Helsinki as previously described.

MMPs as potential molecular targets in epithelial-to-mesenchymal transition driven COPD progression

The Underappreciated Role of Epithelial Mesenchymal Transition in Chronic Obstructive Pulmonary Disease and Its Strong Link to Lung Cancer

Identifying targets for COPD treatment through gene expression analyses.

Eosinophils Promote Pulmonary Matrix Destruction and Emphysema Via Cathepsin L

Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD

Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients.

Pathological changes in the COPD lung mesenchyme--novel lessons learned from in vitro and in vivo studies.

Genetic Screening of MMP1 As a Potential Pathogenic Gene in Chronic Obstructive Pulmonary Disease

Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD)

Molecular Pathogenesis in Chronic Obstructive Pulmonary Disease and Therapeutic Potential by Targeting AMP‐activated Protein Kinase

Molecular pathogenesis in chronic obstructive pulmonary disease and therapeutic potential by targeting AMP-activated protein kinase: AMPK in chronic obstructive pulmonary disease

Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis.

A Functional Mutation in Rs2664370 (T > C) in the 3'UTR of MMP16 Decreases the Risk of COPD Through Interactions with Mir-576-5p: A Family and Population Based Study

Medicine Targeting Epithelial-Mesenchymal Transition to Treat Airway Remodeling and Pulmonary Fibrosis Progression

Comprehensive Landscape of Matrix Metalloproteinases in the Pathogenesis of Idiopathic Pulmonary Fibrosis

Extracellular matrix promotes proliferation, migration and adhesion of airway smooth muscle cells in a rat model of chronic obstructive pulmonary disease via upregulation of the PI3K/AKT signaling pathway

Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives

Targeting Biophysical Microenvironment for Improved Treatment of Chronic Obstructive Pulmonary Disease.

Molecular changes underlying pulmonary emphysema and chronic bronchitis in Chronic Obstructive Pulmonary Disease: An updated review

Transforming growth factor-β1 and SMAD signalling pathway in the small airways of smokers and patients with COPD: potential role in driving fibrotic type-2 epithelial mesenchymal transition

Matrix Metalloproteinases As Novel Biomarker S and Potential Therapeutic Targets in Human Cancer